News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
News|Articles|April 23, 2024 (Updated: April 30, 2024)

Roundtable: Current State of the Pharma Sales and Marketing Sales Force

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement
Executive Roundtable

Related Content

Advertisement

Final Thoughts

ByRobert Alaburda,Fabian Gerlinghaus,Steve Chriscoe,Jason Foster,Brant Nicks
January 2nd 2025

Looking Towards the Future of CAR T-cell Trials

ByRobert Alaburda,Fabian Gerlinghaus,Steve Chriscoe,Jason Foster,Brant Nicks
January 2nd 2025

Patient Selection and Recruitment for Clinical Trials

ByRobert Alaburda,Fabian Gerlinghaus,Steve Chriscoe,Jason Foster,Brant Nicks
January 2nd 2025

Collaboration with Clinical Trial Sites

ByRobert Alaburda,Fabian Gerlinghaus,Steve Chriscoe,Jason Foster,Brant Nicks
January 2nd 2025

Site Selection for CAR T-cell Trials

ByRobert Alaburda,Fabian Gerlinghaus,Steve Chriscoe,Jason Foster,Brant Nicks
January 2nd 2025
Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: FDA Approves Hernexeos

2

The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms

3

FDA Approves Hernexeos Under National Priority Voucher Program

4

FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children

5

What Does the Rollout of Trump Rx Reveal?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us